V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160123 | 20087962 | 1.6 | 81.8 | 03 | 2019-01-15 | 2019-01-29 | Bortezomib +/- Dexamethasone | N | N | DOCETAXEL | 100490191 |
| 20160182 | 20087963 | 1.88 | 106 | Palliative (P) | 2018-12-13 | 2018-12-30 | LENALIDOMIDE | 02 | N | HYDROXYCARBAMIDE | 101181204 |
| 20160321 | 20087964 | 1.67 | 44 | 03 | 2019-04-24 | 2019-05-08 | ACELARATE Trial | 02 | null | NAB-PACLITAXEL | 101866424 |
| 20160350 | 20087965 | 1.71 | 66.5 | 03 | 2021-12-13 | 2021-12-21 | Hydroxycarbamide | 02 | N | FLUOROURACIL + RT | 100378672 |
| 20160619 | 20087967 | 1.6 | 110.2 | 03 | 2018-03-14 | 2018-03-14 | CHOP R - 21 days | 02 | N | ACELARATE TRIAL | 100264511 |
| 20160629 | 20087968 | 1.92 | 62.5 | Adjuvant (A) | null | 2019-07-28 | null | 02 | Y | PHITT E2 PLADO | 101802734 |
| 20160672 | 20087969 | 1.49 | 82.4 | 03 | 2018-12-04 | 2018-12-16 | Azacitidine | 02 | N | RALTITREXED | 100029367 |
| 20160756 | 20087970 | 1.77 | 79.6 | Palliative (P) | 2021-07-19 | 2021-07-19 | ECarboX | null | N | NAB-PACLITAXEL | 101856025 |
| 20161010 | 20087971 | 1.7 | 78 | 03 | 2018-11-16 | 2018-11-16 | EVEROLIMUS | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100243890 |
| 20161127 | 20087972 | 1.6 | 62.6 | 03 | 2018-04-27 | 2018-05-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CHLVPP | 101731971 |
| 20161176 | 20087973 | 1.75 | 77.6 | null | 2019-03-20 | 2019-03-23 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | IBRUTINIB | 101056276 |
| 20161356 | 20087975 | 1.7 | 68.6 | Palliative (P) | 2016-12-10 | 2016-12-21 | NAB PACLITAXEL | 02 | N | IXAZOMIB + LENALIDOMIDE | 100087950 |
| 20161377 | 20087976 | 1.61 | 53.3 | null | 2016-10-23 | 2016-10-30 | PLATO Trials | N | null | PLATO TRIAL | 101086605 |
| 20161556 | 20087977 | null | 89 | Palliative (P) | 2018-01-14 | 2018-01-15 | MPV (cycle 1-4) | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101182578 |
| 20161673 | 20087978 | 1.87 | 63.8 | 03 | 2016-08-10 | 2016-08-10 | Cisplatin + Fluorouracil + RT 5day | 02 | N | PANITUMUMAB | 101540086 |
| 20161884 | 20087979 | 1.59 | 57 | Adjuvant (A) | 2019-09-10 | 2019-09-11 | EVEROLIMUS | null | N | FCARBOST | 100215132 |
| 20162007 | 20087980 | 1.79 | 77.8 | 03 | null | 2019-09-19 | BORTEZOMIB + THALIDOMIDE | Y | N | FEC | 100158300 |
| 20162242 | 20087982 | 1.66 | 74.2 | Palliative (P) | 2019-05-16 | 2019-07-09 | PLATO Trials | 01 | Y | PLATO TRIAL | 101588994 |
| 20162434 | 20087984 | 1.86 | 99.4 | Palliative (P) | 2017-05-23 | 2017-05-24 | CISPLATIN + VINORELBINE | 01 | N | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + RITUXIMAB + VINCRISTINE | 101431124 |
| 20162528 | 20087985 | 1.78 | 62 | null | 2019-01-08 | 2019-01-11 | Cisplatin + Fluorouracil + RT 5day | 02 | N | GEMCITABINE + PACLITAXEL | 101312819 |
| 20162811 | 20087987 | 1.7 | 38.7 | 03 | 2016-08-24 | 2016-08-25 | EOF | null | N | CHOP R | 100063057 |
| 20163011 | 20087988 | 1.66 | 89.7 | Palliative (P) | 2019-01-01 | 2019-01-03 | OXALIPLATIN | 01 | N | CAP + RT | 100465565 |
| 20163327 | 20087989 | 1.62 | 96 | Palliative (P) | null | 2020-02-24 | NAB PACLITAXEL | N | N | DOCETAXEL | 100704145 |
| 20163720 | 20087991 | 1.67 | 68.4 | null | 2017-04-20 | 2017-04-21 | FCarboSt | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100483954 |
| 20163753 | 20087992 | 1.64 | 123.8 | Palliative (P) | 2019-10-19 | 2019-10-19 | ESPAC-4 TRIAL | N | N | GO2 TRIAL | 100060253 |
| 20163832 | 20087993 | 1.49 | 60.6 | Palliative (P) | 2016-03-13 | 2016-03-13 | EEF or EOF | 02 | N | OCTOPUS TRIAL | 100891778 |
| 20164155 | 20087994 | null | 71.85 | null | 2019-04-22 | 2019-05-01 | SCOPE 2 TRIAL | 01 | N | FCARBOST | 100572140 |
| 20164336 | 20087995 | 1.85 | 120.2 | Neo-adjuvant (N) | 2017-12-21 | 2018-01-04 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | N | CAP + RT | 101712263 |
| 20164782 | 20087996 | null | 85.7 | null | 2019-09-26 | 2019-10-05 | Docetaxel | 02 | N | RALTITREXED | 100187380 |
| 20165185 | 20087997 | 1.79 | 56.6 | 03 | 2017-03-31 | 2017-03-31 | SCOPE 2 TRIAL | 02 | null | HYDROXYCARBAMIDE | 101802594 |
| 20165299 | 20087998 | 1.76 | 68 | Palliative (P) | 2020-02-24 | 2020-02-29 | IBRUTINIB | 02 | N | FLUOROURACIL + RT | 100293391 |
| 20165337 | 20087999 | 1.52 | 58.4 | Palliative (P) | 2019-08-27 | 2019-09-25 | ARISTOTLE TRIAL | 02 | Y | SCOPE2 TRIAL | 100734805 |
| 20165600 | 20088001 | 1.71 | 41 | Palliative (P) | 2019-07-01 | 2019-07-01 | null | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100077311 |
| 20165921 | 20088002 | 1.75 | 83 | Palliative (P) | 2018-03-06 | 2018-03-06 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | DOCETAXEL | 100696463 |
| 20166245 | 20088004 | 1.63 | 56.6 | null | 2016-07-26 | 2016-07-28 | MCX | 02 | N | EVEROLIMUS | 100000864 |
| 20166383 | 20088005 | 1.85 | 67 | Adjuvant (A) | 2018-03-06 | 2018-03-26 | GO2 TRIAL | N | N | ACELARATE TRIAL | 101279804 |
| 20166559 | 20088006 | null | 67.9 | null | 2018-08-30 | 2018-09-06 | Temozolomide + RT | 2 | N | FLUOROURACIL + RT | 100036528 |
| 20166940 | 20088007 | 1.67 | 90 | Palliative (P) | 2017-05-20 | 2017-06-14 | NIVOLUMAB | 01 | N | FLUOROURACIL + RT | 101104821 |
| 20166977 | 20088008 | 1.75 | 80 | null | 2019-11-28 | 2019-11-30 | ACELARATE Trial | 01 | N | CISPLATIN + FLUOROURACIL + RT | 101172167 |
| 20166995 | 20088009 | 1.57 | 92.2 | Adjuvant (A) | 2019-09-23 | 2019-10-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | Y | PANITUMUMAB | 101454609 |
| 20167074 | 20088010 | null | 15.7 | null | 2020-09-08 | 2020-09-08 | BUSULFAN | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100949572 |
| 20167087 | 20088011 | 1.66 | 69.6 | 03 | 2019-06-24 | 2019-06-25 | Fluorouracil + Folinic + RT Bossett | 02 | N | MITOMYCIN | 101537234 |
| 20167124 | 20088012 | 1.81 | 70.7 | Adjuvant (A) | 2019-07-28 | 2019-08-10 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101092406 |
| 20167281 | 20088013 | 1.73 | 67 | Adjuvant (A) | 2016-10-27 | 2016-11-05 | OXALIPLATIN | 02 | N | FLUOROURACIL + RT | 101265092 |
| 20167528 | 20088014 | 1.57 | 71.85 | null | 2017-10-07 | 2017-10-12 | ARISTOTLE TRIAL | 02 | N | DOCETAXEL | 101513744 |
| 20167598 | 20088015 | 1.63 | 54.6 | 03 | null | 2020-10-21 | ESPAC-4 TRIAL | 01 | N | GEMCITABINE + PACLITAXEL | 100419704 |
| 20167640 | 20088016 | 1.7 | 54 | 03 | 2019-02-13 | 2019-02-20 | ABVD | 02 | N | OXALIPLATIN | 100378508 |
| 20167655 | 20088017 | 1.88 | 42.2 | Palliative (P) | 2019-06-20 | 2019-06-25 | EEF or EOF | 02 | N | OXALIPLATIN | 100695041 |
| 20167684 | 20088018 | 1.71 | 72.4 | Palliative (P) | null | 2017-08-11 | BORTEZOMIB + THALIDOMIDE | 02 | N | ESHAP | 100773168 |
| 20167749 | 20088019 | 1.65 | 79 | null | 2016-10-23 | 2016-10-27 | null | 01 | N | RALTITREXED | 100769087 |